Invesco’s ACELYRIN SLRN Stock Holding History

Invesco’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-85,520	Closed	-$211K	–	3862
2025 Q1	$211K	Buy	85,520 +59,754	+232%	+$142K	﹤0.01%	3492
2024 Q4	$80.9K	Buy	25,766 +2,777	+12%	+$13.4K	﹤0.01%	3648
2024 Q3	$113K	Sell	22,989 -1,128	-5%	-$5.82K	﹤0.01%	3602
2024 Q2	$106K	Sell	24,117 -1,956	-8%	-$9.17K	﹤0.01%	3744
2024 Q1	$176K	Buy	26,073 +5,723	+28%	+$43.5K	﹤0.01%	3671
2023 Q4	$152K	Buy	20,350 +2,397	+13%	+$20.5K	﹤0.01%	3614
2023 Q3	$183K	Buy	+17,953	New	+$381K	﹤0.01%	3622

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Invesco's SLRN Position: Q2 2025 in Review

Invesco sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 85,520 shares — an estimated $211K sold.

Invesco first reported a position in SLRN in Q3 2023 and held it in 7 quarters. The position peaked at $211K in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Invesco reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Invesco sold 85,520 ACELYRIN shares in Q2 2025, an estimated $211K.
Invesco first reported a position in ACELYRIN in Q3 2023 and held it in 7 quarters.
Invesco's ACELYRIN position peaked at $211K in Q1 2025.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.